Burning Rock Biotech Limi...

NASDAQ: BNR · Real-Time Price · USD
6.98
-0.01 (-0.14%)
At close: Aug 14, 2025, 3:59 PM
6.98
0.00%
Pre-market: Aug 15, 2025, 06:10 AM EDT

Burning Rock Biotech Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
515.82M 537.43M 563.24M 507.86M
Cost of Revenue
153.42M 174.21M 183.2M 143.72M
Gross Profit
362.4M 363.23M 380.04M 364.15M
Operating Income
-357.56M -669.32M -980.41M -797.06M
Interest Income
12.21M 17.96M 9.46M 3.46M
Pretax Income
-340.74M -651.3M -969.25M -795.8M
Net Income
-346.63M -653.69M -971.23M -796.7M
Selling & General & Admin
452.54M 685.53M 938.58M 793.35M
Research & Development
232.29M 347.02M 421.87M 367.86M
Other Expenses
35.13M n/a 152K 199K
Operating Expenses
719.96M 1.03B 1.36B 1.16B
Interest Expense
n/a n/a n/a 1.54M
Selling & Marketing Expenses
190.9M 247.71M 370.29M 303.1M
Cost & Expenses
873.38M 1.21B 1.54B 1.3B
Income Tax Expense
5.88M 2.39M 1.99M 899K
Shares Outstanding (Basic)
1.03M 1.02M 1.04M 1.04M
Shares Outstanding (Diluted)
1.03M 1.02M 1.04M 1.04M
EPS (Basic)
-341.5 -638.3 -951.1 -754.6
EPS (Diluted)
-341.5 -638.3 -951.1 -754.6
EBITDA
-270.23M -517.9M -856.31M -746.5M
EBIT
-322.43M -651.3M -980.41M -794.26M
Depreciation & Amortization
52.2M 133.4M 124.1M 47.77M